These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31435484)

  • 21. Oxytocin receptor antagonists for inhibiting preterm labour.
    Flenady V; Reinebrant HE; Liley HG; Tambimuttu EG; Papatsonis DN
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD004452. PubMed ID: 24903678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials.
    EPPPIC Group
    Lancet; 2021 Mar; 397(10280):1183-1194. PubMed ID: 33773630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial.
    Price JT; Vwalika B; Freeman BL; Cole SR; Saha PT; Mbewe FM; Phiri WM; Peterson M; Muyangwa D; Sindano N; Mwape H; Smithmyer ME; Kasaro MP; Rouse DJ; Goldenberg RL; Chomba E; Stringer JSA
    Lancet HIV; 2021 Oct; 8(10):e605-e613. PubMed ID: 34509197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 17 alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial.
    Winer N; Bretelle F; Senat MV; Bohec C; Deruelle P; Perrotin F; Connan L; Vayssière C; Langer B; Capelle M; Azimi S; Porcher R; Rozenberg P;
    Am J Obstet Gynecol; 2015 Apr; 212(4):485.e1-485.e10. PubMed ID: 25448515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 17-Hydroxyprogesterone caproate (17OHP-C) coverage among eligible women delivering at 2 North Carolina hospitals in 2012 and 2013: A retrospective cohort study.
    Stringer EM; Vladutiu CJ; Manuck T; Verbiest S; Ollendorff A; Stringer JS; Menard MK
    Am J Obstet Gynecol; 2016 Jul; 215(1):105.e1-105.e12. PubMed ID: 26829508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications.
    Conde-Agudelo A; Romero R
    Am J Obstet Gynecol; 2016 Feb; 214(2):235-242. PubMed ID: 26450404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison the efficacy of vaginal progesterone
    Alavi A; Ranjbar A; Atighpoor F; Zare S
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7438-7444. PubMed ID: 34470137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial.
    Rehal A; Benkő Z; De Paco Matallana C; Syngelaki A; Janga D; Cicero S; Akolekar R; Singh M; Chaveeva P; Burgos J; Molina FS; Savvidou M; De La Calle M; Persico N; Quezada Rojas MS; Sau A; Greco E; O'Gorman N; Plasencia W; Pereira S; Jani JC; Valino N; Del Mar Gil M; Maclagan K; Wright A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2021 Jan; 224(1):86.e1-86.e19. PubMed ID: 32598909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment options and recommendations to reduce preterm births in women with short cervix.
    Slager J; Lynne S
    J Midwifery Womens Health; 2012 Jul; 57 Suppl 1():S12-8. PubMed ID: 22776244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth.
    Dodd JM; Jones L; Flenady V; Cincotta R; Crowther CA
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD004947. PubMed ID: 23903965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does vaginal progesterone prevent recurrent preterm birth in women with a singleton gestation and a history of spontaneous preterm birth? Evidence from a systematic review and meta-analysis.
    Conde-Agudelo A; Romero R
    Am J Obstet Gynecol; 2022 Sep; 227(3):440-461.e2. PubMed ID: 35460628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Placental histology for targeted risk assessment of recurrent spontaneous preterm birth.
    Suresh S; Freedman A; Adams M; Hirsch E; Ernst LM
    Am J Obstet Gynecol; 2024 Apr; 230(4):452.e1-452.e11. PubMed ID: 37751829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of neonatal morbidity and very preterm delivery using maternal steroid biomarkers in early gestation.
    Patil AS; Grotegut CA; Gaikwad NW; Dowden SD; Haas DM
    PLoS One; 2021; 16(1):e0243585. PubMed ID: 33406107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial.
    Price JT; Vwalika B; Freeman BL; Cole SR; Mulenga HB; Winston J; Mbewe FM; Chomba E; Mofenson LM; Rouse DJ; Goldenberg RL; Stringer JSA
    BMC Pregnancy Childbirth; 2019 Feb; 19(1):81. PubMed ID: 30813934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaginal progesterone pessaries for pregnant women with a previous preterm birth to prevent neonatal respiratory distress syndrome (the PROGRESS Study): A multicentre, randomised, placebo-controlled trial.
    Crowther CA; Ashwood P; McPhee AJ; Flenady V; Tran T; Dodd JM; Robinson JS;
    PLoS Med; 2017 Sep; 14(9):e1002390. PubMed ID: 28949973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progestogens and prevention of preterm birth in women at risk.
    Prescrire Int; 2016 Jul; 25(173):185-188. PubMed ID: 30730653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of follow-up cervical length screening in low-risk women with a cervical length of 26 to 29 mm.
    Boelig RC; Kripalu V; Chen SL; Cruz Y; Roman A; Berghella V
    Am J Obstet Gynecol; 2021 Aug; 225(2):179.e1-179.e6. PubMed ID: 33652056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intramuscular 17α-hydroxyprogesterone caproate to decrease preterm delivery in women with placenta praevia: a randomised controlled trial.
    Shaamash AH; Ali MK; Attyia KM
    J Obstet Gynaecol; 2020 Jul; 40(5):633-638. PubMed ID: 31670998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevention of spontaneous preterm birth (excluding preterm premature rupture of membranes): Guidelines for clinical practice - Text of the Guidelines (short text)].
    Sentilhes L; Sénat MV; Ancel PY; Azria E; Benoist G; Blanc J; Brabant G; Bretelle F; Brun S; Doret M; Ducroux-Schouwey C; Evrard A; Kayem G; Maisonneuve E; Marcellin L; Marret S; Mottet N; Paysant S; Riethmuller D; Rozenberg P; Schmitz T; Torchin H; Langer B
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1446-1456. PubMed ID: 27836377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of 17α-hydroxyprogesterone caproate in prevention of preterm delivery.
    Saghafi N; Khadem N; Mohajeri T; Shakeri MT
    J Obstet Gynaecol Res; 2011 Oct; 37(10):1342-5. PubMed ID: 21564406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.